Home » Metro » Health and Science
Cancer drug shortage over soon
Print Edition
A MEDICINE used to treat children with cancer that has been in short supply for a couple of years, might soon be more readily available.
A company that produces the drug — dactinomycin — is expected to recommence production next month after passing government checks.
Several companies that used to make it stopped doing so because it is not very lucrative — a ceiling price was set by the government many years ago,Changjiang Times reported.
“Dactinomycin has been used in clinical practice since the 1960s with proven effects,” said Dr Tang Jingyan, director of hematology and oncology department from Shanghai Children’s Medical Center.
The antibiotic costs 20 yuan (US$3.10) per injection, Tang said, adding that her hospital currently has only 10 shots left in stock.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
